biOasis Receives Compelling Data From Texas Tech University On Its Herceptin(R) BT2111 Program - Yahoo! Finance
biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that research underway at Texas Tech University Health Sciences Center (TTUHSC) has yielded some compelling data on preclinical studies designed to evaluate the pharmacokinetics of BT2111 (a proprietary conjugate of Transcend and Herceptin®) in animal models of breast cancer metastasis to the brain.
Read the full story >>
TTUHSC Celebration of Life Service was held March 25th in remembrance of Tom McGovern, Ed.D.
TTUHSC has been named as a Military Friendly® School for 2022-2023. Among graduate schools, TTUHSC ranked fourth in the nation, achieving Gold award status.
On March 16, fourth-year TTUHSC Jerry H. Hodge School of Pharmacy students interested in completing a residency after they graduate in May, learned where they would spend the next stage of their training during the Pharmacy Residency Match Day.
TTUHSC hosted “Building the Basin: a Permian Basin Health Care Workforce Summit” Oct. 4.
CPRIT recently awarded a $1 million prevention grant to Rakhshanda Rahman, M.D., Rebeccah Baucom, M.D., and John Kidwell, M.D., from the TTUHSC School of Medicine.
The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.